Xcelience Opens Expanded Tampa, Florida, Headquarters
11/02/2015
The company provides services from preformulation through global clinical supplies packaging and distribution to international pharmaceutical and biotechnology clients for Phases I-IV.
According to the firm, the building houses preformulation and formulation development labs and suites, as well as analytical and stability services, as well as the executive headquarters. Build out plans for a new analytical lab is developing. The company's previous headquarters on West Laurel Street in Tampa is transitioning to provide clinical trial and small-scale commercial manufacturing.
"This year marks a rapid expansion in our service offerings," says Derek Hennecke, President/CEO. "In July we integrated with Powdersize because so many of our clients needed industry-leading micronization services. Now, with this new facility, we will be able to increase capacity throughout the organization. More capacity means we can be more flexible in dealing with changing client needs and timelines."
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024